KR100647268B1 - 아목시실린을 포함하는 동물용 항생제 조성물 및 이를포함하는 수성현탁액 - Google Patents
아목시실린을 포함하는 동물용 항생제 조성물 및 이를포함하는 수성현탁액 Download PDFInfo
- Publication number
- KR100647268B1 KR100647268B1 KR1020050108737A KR20050108737A KR100647268B1 KR 100647268 B1 KR100647268 B1 KR 100647268B1 KR 1020050108737 A KR1020050108737 A KR 1020050108737A KR 20050108737 A KR20050108737 A KR 20050108737A KR 100647268 B1 KR100647268 B1 KR 100647268B1
- Authority
- KR
- South Korea
- Prior art keywords
- amoxicillin
- antibiotic composition
- composition
- antibiotic
- sodium
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
구분 | 조 성(중량%) | pH | 용해도 | ||
아목시실린삼수화물 | 구연산나트륨 | 건조탄산나트륨/제3인산나트륨 | |||
실시예 1 | 5.9 | 92.1 | 2.0 | 9.13 | O |
실시예 2 | 11.8 | 85.2 | 3.0 | 8.58 | O |
실시예 3 | 23.5 | 70.5 | 6.0 | 8.55 | O |
실시예 4 | 35.3 | 55.7 | 9.0 | 8.60 | O |
실시예 5 | 47.1 | 39.1 | 13.8 | 8.55 | O |
실시예 6 | 58.8 | 26.2 | 15.0 | 8.59 | O |
실시예 7 | 70.6 | 11.8 | 17.6 | 8.49 | O |
실시예 8 | 71.8 | 9.9 | 18.3 | 8.53 | O |
실시예 9 | 72.9 | 8.5 | 18.6 | 8.51 | O |
실시예 10 | 74.1 | 7.0 | 18.9 | 8.49 | O |
실시예 11 | 75.3 | 5.5 | 19.2 | 8.51 | O |
실시예 12 | 76.5 | 4.0 | 19.5 | 8.53 | O |
실시예 13 | 77.7 | 2.5 | 19.8 | 8.57 | O |
비교예 1 | 82.4 | 0 | 17.6 | 8.27 | X |
1회 | 2회 | 3회 | 4회 | 5회 | 6회 | 7회 | 8회 이상 | |
실시예 6 | △ | △ | △ | ○ | ○ | ○ | ○ | ○ |
비교예 2 | △ | △ | △ | △ | △ | △ | ○ | ○ |
비교예 3 | △ | △ | △ | △ | △ | ○ | ○ | ○ |
구분 | initial | 1시간 | 3시간 | 5시간 | 1일 | 2일 | 5일 |
실시예 6 | 15.8mg/ml | 15.5mg/ml | 14.7mg/ml | 14.7mg/ml | 13.1mg/ml | 11.4mg/ml | 7.5mg/ml |
100.0% | 98.0% | 93.0% | 93.0% | 82.9% | 72.2% | 47.5% | |
비교예 2 | 14.6mg/ml | 11.7mg/ml | 8.9mg/ml | 5.8mg/ml | 3.7mg/ml | 1.8mg/ml | 1.6mg/ml |
100.0% | 80.1% | 61.0% | 39.7% | 25.3% | 12.3% | 10.9% | |
비교예 3 | 11.9mg/ml | 4.9mg/ml | 2.6mg/ml | 1.5mg/ml | 1.4mg/ml | 1.3mg/ml | 0.9mg/ml |
100.0% | 41.2% | 21.9% | 12.6% | 11.4% | 11.0% | 7.6% |
Claims (4)
- 아목시실린 항생제 조성물에 있어서,아목시실린 삼수화물과 함께 구연산나트륨 및건조탄산나트륨 또는 제3인산나트륨을 포함함을 특징으로 하는 동물용 항생제 조성물.
- 제1항에 있어서,상기 아목시실린 삼수화물은 5.9 내지 77.7중량%,구연산나트륨은 2.5 내지 92.1중량%,건조탄산나트륨 또는 제3인산나트륨은 2.0 내지 19.8중량%가 포함됨을 특징으로 하는 동물용 항생제 조성물.
- 제1항에 있어서,상기 아목시실린 삼수화물은 58.8중량%,구연산나트륨은 26.2중량%,건조탄산나트륨 또는 제3인산나트륨은 15.0중량%가 포함됨을 특징으로 하는 동물용 항생제 조성물.
- 제1항 내지 제3항 중 어느 한 항에 의한 항생제 조성물이 5 내지 66 중량%를 포함됨을 특징으로 하는 수성현탁액.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050108737A KR100647268B1 (ko) | 2005-11-14 | 2005-11-14 | 아목시실린을 포함하는 동물용 항생제 조성물 및 이를포함하는 수성현탁액 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050108737A KR100647268B1 (ko) | 2005-11-14 | 2005-11-14 | 아목시실린을 포함하는 동물용 항생제 조성물 및 이를포함하는 수성현탁액 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100647268B1 true KR100647268B1 (ko) | 2006-11-23 |
Family
ID=37712825
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050108737A KR100647268B1 (ko) | 2005-11-14 | 2005-11-14 | 아목시실린을 포함하는 동물용 항생제 조성물 및 이를포함하는 수성현탁액 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100647268B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101485431B1 (ko) * | 2013-01-08 | 2015-01-22 | 참신약품 주식회사 | 아목시실린을 포함하는 어류용 항생제 조성물 |
KR20240126665A (ko) | 2023-02-14 | 2024-08-21 | 김대철 | 아목시실린을 포함하는 동물용 주사제 조성물. |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3969524A (en) | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
KR810002136B1 (ko) * | 1977-05-06 | 1981-12-29 | 아아르 스미자아 | 아목시실린 나트륨 함유 주사용 약제조성물의 제조방법 |
US6051254A (en) * | 1990-04-07 | 2000-04-18 | Smithkline Beecham Plc | Pharmaceutical formulation |
US20030118547A1 (en) | 2000-01-27 | 2003-06-26 | Vandenberg Grant William | Composition for intestinal delivery |
-
2005
- 2005-11-14 KR KR1020050108737A patent/KR100647268B1/ko active IP Right Grant
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3969524A (en) | 1974-08-13 | 1976-07-13 | Hoffmann-La Roche Inc. | Stable amoxicillin dosage form |
KR810002136B1 (ko) * | 1977-05-06 | 1981-12-29 | 아아르 스미자아 | 아목시실린 나트륨 함유 주사용 약제조성물의 제조방법 |
US6051254A (en) * | 1990-04-07 | 2000-04-18 | Smithkline Beecham Plc | Pharmaceutical formulation |
US20030118547A1 (en) | 2000-01-27 | 2003-06-26 | Vandenberg Grant William | Composition for intestinal delivery |
Non-Patent Citations (1)
Title |
---|
1020050108737 - 663210 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101485431B1 (ko) * | 2013-01-08 | 2015-01-22 | 참신약품 주식회사 | 아목시실린을 포함하는 어류용 항생제 조성물 |
KR20240126665A (ko) | 2023-02-14 | 2024-08-21 | 김대철 | 아목시실린을 포함하는 동물용 주사제 조성물. |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2828685C (en) | Stable compositions of tetrahydrobiopterin | |
EP1468683A2 (en) | Pharmaceutical composition for oral use with angiotensin-II-antagonistic activity and method of preparing it | |
KR20090090387A (ko) | 음료수 시스템 내에 추가하기 위한 플로르페니콜의 비등성 제형 | |
KR20100085162A (ko) | 속방성 고체 제형, 제조 및 이의 용도 | |
UA29513C2 (uk) | Фармацевтична композиція, що включає (е)-3,5-дигідрокси-7-[4'-4''-фторфеніл-2'-циклопропілхінолін-3'-іл]-6- гептенову кислоту | |
CA2581303A1 (en) | Compositions containing piperacillin, tazobactam and a aminocarboxilic acid in a sodium lactate diluent | |
CN101732246A (zh) | 莫西沙星水溶液型注射剂 | |
JP2006520346A (ja) | 制御放出システム | |
CN112716902A (zh) | 一种氟苯尼考粉及其制备方法 | |
WO2018007466A1 (en) | Methods for the preparation of a levothyroxine solution | |
KR100647268B1 (ko) | 아목시실린을 포함하는 동물용 항생제 조성물 및 이를포함하는 수성현탁액 | |
CN106727578A (zh) | 复方磺胺氯达嗪钠粉及其制备方法 | |
US4585782A (en) | Azole derivatives antimycotic agents which release the active compounds at a relatively high rate | |
WO2015070131A1 (en) | Compositions and methods of treatment comprising fosfomycin disodium | |
SI20411A (sl) | Vodotopni praški za peroralno raztopino in njihova uporaba | |
CN108272756B (zh) | 一种阿莫西林可溶性粉及其制备方法 | |
CN102697751A (zh) | 一种畜禽专用恩诺沙星泡腾分散片及其制备方法 | |
CN105560187A (zh) | 阿莫西林可溶性粉的制备方法 | |
CN101843580A (zh) | 匹多莫德注射类制剂的制备方法 | |
KR101485431B1 (ko) | 아목시실린을 포함하는 어류용 항생제 조성물 | |
EP0354453B1 (en) | Antimicrobial agent for animals | |
KR100365679B1 (ko) | 기호성이 우수한 엔로프록사신 프리믹스 조성물 및 그제조방법 | |
KR102058133B1 (ko) | 혼합제제 내 항생제 용해도를 향상시킬 수 있는 면역 증강용 조성물 및 이의 용도 | |
CA2836497C (en) | Fast dissolving azaperone granulate formulation | |
CN104666252A (zh) | 头孢替唑钠冻干粉针的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120830 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130930 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140905 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20151104 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20161104 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171101 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20181106 Year of fee payment: 13 |